Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years
…, BF HAYNES, P KATZ, SM WOLFF - Annals of internal …, 1983 - acpjournals.org
Eighty-five patients with Wegener's granulomatosis were studied for 21 years at the National
Institutes of Health. Patients were treated with a protocol consisting of cyclophosphamide, 2 …
Institutes of Health. Patients were treated with a protocol consisting of cyclophosphamide, 2 …
The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature
MJ CHUSID, DC DALE, BC WEST, SM WOLFF - Medicine, 1975 - journals.lww.com
A. Demography The age at onset of symptoms attributable to HES ranged from 5 to 80 years,
while the average age at the time of disease onset was 38 years. The decade of greatest …
while the average age at the time of disease onset was 38 years. The decade of greatest …
The role of interleukin-1 in disease
CA Dinarello, SM Wolff - New England Journal of Medicine, 1993 - Mass Medical Soc
The interleukin-1 family consists of three structurally related polypeptides. The first two are
interleukin-1α and interleukin-1β, each of which has a broad spectrum of both beneficial and …
interleukin-1α and interleukin-1β, each of which has a broad spectrum of both beneficial and …
The effect of dietary supplementation with n—3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells
…, PC Weber, EJ Schaefer, SM Wolff… - … England Journal of …, 1989 - Mass Medical Soc
We examined whether the synthesis of interleukin-1 or tumor necrosis factor, two cytokines
with potent inflammatory activities, is influenced by dietary supplementation with n—3 fatty …
with potent inflammatory activities, is influenced by dietary supplementation with n—3 fatty …
New Giemsa method for the differential staining of sister chromatids
P Perry, S Wolff - Nature, 1974 - nature.com
IF human lymphocytes 1 or Chinese hamster 2 cells are treated with the base analogue 5-bromodeoxyuridine
(BrdU) in the latter part of the S period, Giemsa stained chromosomes …
(BrdU) in the latter part of the S period, Giemsa stained chromosomes …
[HTML][HTML] CrystalExplorer: A program for Hirshfeld surface analysis, visualization and quantitative analysis of molecular crystals
…, MJ Turner, JJ McKinnon, SK Wolff… - Journal of Applied …, 2021 - scripts.iucr.org
CrystalExplorer is a native cross-platform program supported on Windows, MacOS and Linux
with the primary function of visualization and investigation of molecular crystal structures, …
with the primary function of visualization and investigation of molecular crystal structures, …
Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo
SD Wolff, RS Balaban - Magnetic resonance in medicine, 1989 - Wiley Online Library
In this study the exchange between 1 H magnetization in “free” water ( 1 H f ) and that in a
pool with restricted motion ( 1 H r ) was observed in tissues in vivo using NMR saturation …
pool with restricted motion ( 1 H r ) was observed in tissues in vivo using NMR saturation …
Detection of circulating tumor necrosis factor after endotoxin administration
…, CA Dinarello, A Cerami, SM Wolff… - … England Journal of …, 1988 - Mass Medical Soc
Cytokines, products of stimulated macrophages, are thought to mediate many host responses
to bacterial infection, but increased circulating cytokine concentrations have not been …
to bacterial infection, but increased circulating cytokine concentrations have not been …
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
CA Dinarello, JG Cannon, SM Wolff… - The Journal of …, 1986 - rupress.org
Recombinant human tumor necrosis factor (rTNF alpha) injected intravenously into rabbits
produces a rapid-onset, monophasic fever indistinguishable from the fever produced by rIL-1. …
produces a rapid-onset, monophasic fever indistinguishable from the fever produced by rIL-1. …
[PDF][PDF] Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
…, R Champlin, SA Goodman, SN Wolff… - Journal of clinical …, 1997 - researchgate.net
Purpose: Recipients of allogeneic bone marrow transplants (BMTs) who have relapsed may
attain complete remissions when treated with transfusions of leukocytes obtained from the …
attain complete remissions when treated with transfusions of leukocytes obtained from the …